HELENA M SPOONER

Allopathic & Osteopathic Physicians|Family Medicine CAIRO, NY NPI 1821869348

General Payments — all program years on this page

$375.38

  • Category: General Payments
  • Program years: PY2024
  • Record count: 21
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $375.38 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $375.3821

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2024 $375.3821

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1108564771 Novo Nordisk Inc $19.74 09/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108566497 Novo Nordisk Inc $11.73 05/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108567457 Novo Nordisk Inc $18.75 04/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108569233 Novo Nordisk Inc $16.23 10/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108570428 Novo Nordisk Inc $14.97 06/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108571238 Novo Nordisk Inc $20.29 05/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108572008 Novo Nordisk Inc $14.86 06/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108573010 Novo Nordisk Inc $14.65 08/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116516892 GlaxoSmithKline, LLC. $20.90 04/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116709401 GlaxoSmithKline, LLC. $19.07 06/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117691032 Amgen Inc. $18.09 12/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1123302860 AstraZeneca Pharmaceuticals LP $17.95 05/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1123305034 AstraZeneca Pharmaceuticals LP $20.21 04/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1123308188 AstraZeneca Pharmaceuticals LP $16.68 07/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125292582 Abbott Laboratories $19.71 12/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1128386458 Exact Sciences Corporation $16.78 05/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1128386462 Exact Sciences Corporation $25.61 08/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132307627 SCPHARMACEUTICALS INC. $14.73 10/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135652933 Lilly USA, LLC $18.72 05/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135680299 Lilly USA, LLC $18.42 08/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148362902 Axsome Therapeutics, Inc. $17.29 07/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.